About the Event
In this installment of Internal Medicine Grand Rounds, Adewole “Ade” Adamson, M.D., MPP, presents “How Diagnostic Practice Shapes Cancer Epidemiology.” Adamson is an associate professor in the Department of Internal Medicine at Dell Medical School.
For more information, contact Lyndsey Loughran.
Objectives
By the end of this presentation, the audience participant should be able to:
- Evaluate the potential harms of overdiagnosis, including psychological, financial, and treatment-related consequences
- Describe the epidemiologic and clinical factors that contribute to rising cancer incidence without corresponding increases in mortality.
- Define the concept of overdiagnosis in cancer and distinguish it from related concepts such as misdiagnosis and overtreatment.
Target Audience
- Primary: Department of Internal Medicine faculty, residents, fellows
- Secondary: Family Medicine faculty and students, medical students
Attributes/Competencies
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient Care; Medical Knowledge; Practice-Based Learning and Improvement; Professionalism; Systems-Based Practice
- IOM: Provide Patient-Centered Care; Work in Interdisciplinary Teams; Employ Evidence-Based Practice; Apply Quality Improvement
- IECC: Interprofessional Communication; Teams and Teamwork
Speaker Disclosure
Ade Adamson, M.D, speaker for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Planner Disclosure
Beth Nelson, M.D.; Grace Farris, M.D.; Brittany Rosales, M.D.; Dalia El-Bejjani, M.D.; Sherine Salib, M.D., FACP; Anokhi Jambusaria-Pahlajani, M.D., MSCE; Scott Sellinger, M.D.; Trisha Parekh, D.O., M.S.; Charles Hyman, M.D.; Ollieta Nicholas, MBA, FACHE; and Lyndsey Loughran, MHQS, planners for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.
Yan Liu, M.D., Ph.D., received royalties and is a patent holder for G1 Therapeutics. He is an advisory board member for Pfizer.
Brian Lee, M.D., is on the scientific advisory board of HealthMap Solution Inc.
The CME Advisory Committee, reviewers of this educational activity, have no relevant relationship(s) with ineligible companies to disclose.
All of the relevant financial relationships listed have been mitigated.
Accreditation Statement
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.